BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirota K. Sepsis and the orexin system. J Anesth 2016;30:919-22. [PMID: 27580992 DOI: 10.1007/s00540-016-2246-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
2 Akaishi M, Hashiba E, Takekawa D, Kushikata T, Hirota K. Plasma orexin A does not reflect severity of illness in the intensive care units patients with systemic inflammation. JA Clin Rep 2022;8. [DOI: 10.1186/s40981-022-00498-4] [Reference Citation Analysis]
3 Tunisi L, Forte N, Fernández-Rilo AC, Mavaro I, Capasso R, D'Angelo L, Milić N, Cristino L, Di Marzo V, Palomba L. Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier. Front Endocrinol (Lausanne) 2019;10:219. [PMID: 31024456 DOI: 10.3389/fendo.2019.00219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]